These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Lethality and pathogenesis of airborne infection with filoviruses in A129 α/β -/- interferon receptor-deficient mice. Lever MS; Piercy TJ; Steward JA; Eastaugh L; Smither SJ; Taylor C; Salguero FJ; Phillpotts RJ J Med Microbiol; 2012 Jan; 61(Pt 1):8-15. PubMed ID: 21852521 [TBL] [Abstract][Full Text] [Related]
7. Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa. Leroy EM; Gonzalez JP; Baize S Clin Microbiol Infect; 2011 Jul; 17(7):964-76. PubMed ID: 21722250 [TBL] [Abstract][Full Text] [Related]
8. Marburg and Ebola virus infections in laboratory non-human primates: a literature review. Schou S; Hansen AK Comp Med; 2000 Apr; 50(2):108-23. PubMed ID: 10857001 [TBL] [Abstract][Full Text] [Related]
9. Geographic potential of disease caused by Ebola and Marburg viruses in Africa. Peterson AT; Samy AM Acta Trop; 2016 Oct; 162():114-124. PubMed ID: 27311387 [TBL] [Abstract][Full Text] [Related]
10. Emerging and reemerging of filoviruses. Feldmann H; Slenczka W; Klenk HD Arch Virol Suppl; 1996; 11():77-100. PubMed ID: 8800808 [TBL] [Abstract][Full Text] [Related]
11. Characteristics of Filoviridae: Marburg and Ebola viruses. Beer B; Kurth R; Bukreyev A Naturwissenschaften; 1999 Jan; 86(1):8-17. PubMed ID: 10024977 [TBL] [Abstract][Full Text] [Related]
12. Drivers of African Filovirus (Ebola and Marburg) Outbreaks. Stephens PR; Sundaram M; Ferreira S; Gottdenker N; Nipa KF; Schatz AM; Schmidt JP; Drake JM Vector Borne Zoonotic Dis; 2022 Sep; 22(9):478-490. PubMed ID: 36084314 [TBL] [Abstract][Full Text] [Related]
13. Marburg and Ebola--arming ourselves against the deadly filoviruses. Peters CJ N Engl J Med; 2005 Jun; 352(25):2571-3. PubMed ID: 15972860 [No Abstract] [Full Text] [Related]
14. Other viral bioweapons: Ebola and Marburg hemorrhagic fever. Salvaggio MR; Baddley JW Dermatol Clin; 2004 Jul; 22(3):291-302, vi. PubMed ID: 15207310 [TBL] [Abstract][Full Text] [Related]
15. Laboratory detection and diagnosis of filoviruses. Wang YP; Zhang XE; Wei HP Virol Sin; 2011 Apr; 26(2):73-80. PubMed ID: 21468930 [TBL] [Abstract][Full Text] [Related]
16. Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against Sudan ebolavirus and Marburg virus. Wolfe DN; Taylor MJ; Zarrabian AG Hum Vaccin Immunother; 2020 Nov; 16(11):2855-2860. PubMed ID: 32275465 [TBL] [Abstract][Full Text] [Related]
17. Reemergence of Marburgvirus disease: Update on current control and prevention measures and review of the literature. Elsheikh R; Makram AM; Selim H; Nguyen D; Le TTT; Tran VP; Elaziz Khader SA; Huy NT Rev Med Virol; 2023 Sep; 33(5):e2461. PubMed ID: 37208958 [TBL] [Abstract][Full Text] [Related]
18. Development of treatment strategies to combat Ebola and Marburg viruses. Paragas J; Geisbert TW Expert Rev Anti Infect Ther; 2006 Feb; 4(1):67-76. PubMed ID: 16441210 [TBL] [Abstract][Full Text] [Related]
19. Ecology of Marburg and Ebola viruses: speculations and directions for future research. Monath TP J Infect Dis; 1999 Feb; 179 Suppl 1():S127-38. PubMed ID: 9988176 [TBL] [Abstract][Full Text] [Related]
20. Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions. Bausch DG; Sprecher AG; Jeffs B; Boumandouki P Antiviral Res; 2008 Apr; 78(1):150-61. PubMed ID: 18336927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]